Singapore markets closed

RegenETP, Inc. (RGTPQ)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.03100.0000 (0.00%)
At close: 10:39AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 228.66k
Enterprise value -3.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.65
Price/book (mrq)0.02
Enterprise value/revenue -5.45
Enterprise value/EBITDA 0.62

Trading information

Stock price history

Beta (5Y monthly) 2.00
52-week change 3-92.31%
S&P500 52-week change 326.49%
52-week high 30.4400
52-week low 30.0100
50-day moving average 30.0526
200-day moving average 30.0556

Share statistics

Avg vol (3-month) 32.22k
Avg vol (10-day) 31.01k
Shares outstanding 57.38M
Implied shares outstanding 67.38M
Float 86.94M
% held by insiders 13.40%
% held by institutions 10.00%
Shares short (31 May 2023) 4120.43k
Short ratio (31 May 2023) 43.19
Short % of float (31 May 2023) 41.69%
Short % of shares outstanding (31 May 2023) 41.63%
Shares short (prior month 28 Apr 2023) 4120.6k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 412 Jan 2016
Last split factor 21:25
Last split date 317 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-29,868.49%

Management effectiveness

Return on assets (ttm)-56.67%
Return on equity (ttm)-54.97%

Income statement

Revenue (ttm)73k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -20.6M
Net income avi to common (ttm)-8.3M
Diluted EPS (ttm)-0.6000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.39M
Total cash per share (mrq)0.89
Total debt (mrq)2.95M
Total debt/equity (mrq)23.77%
Current ratio (mrq)4.11
Book value per share (mrq)1.74

Cash flow statement

Operating cash flow (ttm)-21.64M
Levered free cash flow (ttm)-11.39M